Until 16.05.2025, Charles University has trial access to the NEJM Evidence and NEJM AI journals.
NEJM Evidence presents innovative, original research and fresh ideas in clinical trial design and decision-making. The journal provides a critical evaluation of research methods and results to support clinical decision-making.
The original research that NEJM Evidence publishes falls along the full spectrum of human investigation — from first-in-human studies that offer insight into the safety and potential efficacy of novel therapeutics to the late-stage confirmatory trials that solidify the evidence base that forms the foundation of clinical practice. The journal also offers many unique article types and features — designed to challenge clinical thinking and connect evidence with medical practice.
Welcome Video: https://youtu.be/-hkVijsXeSI?si=1VIcvwNufDPcG54J
NEJM AI helps clinicians and researchers identify and evaluate state-of-the-art applications of artificial intelligence in clinical medicine. In addition to original research, NEJM AI provides reviews and policy perspectives for practicing physicians, clinician leaders, computer scientists, and policymakers and regulators.
Access to the journals is via the UKAŽ Discovery service
